Urol. praxi, 2014; 15(5): 219-220

Arterial hypertension and benign prostatic hyperplasia are specific aging men diseases.

MUDr.Petr Hušek, MUDr.Jaroslav Pacovský, Ph.D., MUDr.Lukáš Holub, MUDr.Josef Košina, doc.MUDr.Miloš Broďák, Ph.D.
Urologická klinika FN a LF UK Hradec Králové

Adrenergic nervous system plays main role in both cases pathogenesis. The specific receptors blocking in the target tissues decreases

adrenergic control of the smooth muscles localized in prostate and arterial wall. It makes positive effect as in the bladder neck obstruction

as the arterial hypertension. Alpha receptors blockers, primary developed for the arterial hypertension treatment, are the first

choice medicament therapy of benign prostate hyperplasia at present. Alpha receptors blockers can be used for uncontrolled arterial

hypertension therapy in combination with other drugs only, not in monotherapy.

Keywords: hypertension, BPH, adrenergic nervous system

Published: December 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hušek P, Pacovský J, Holub L, Košina J, Broďák M. Arterial hypertension and benign prostatic hyperplasia are specific aging men diseases. Urol. praxi. 2014;15(5):219-220.
Download citation

References

  1. Veselský Z, Višňovský P, Macek P, Jurášková B. Benigní hyperplazie prostaty a hypertenze. Interní med. 2004; (2): 89-91.
  2. Sladká J. Benigní hyperplazie a hypertenze - možnosti současné léčby. Urologie. 1/2000: 16.
  3. Poo JT. Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia. British Journal od Clinical Praktice, Supplement 1994; 73: 13-17.
  4. Michel MC, Hermann U, Schumacher H, Mehlburger L, Goepel M. Association of hypertension with symptoms od benign prostatic hyperlasia. The Journal of Urology 2004 Oct; 172(4): 1390-1393. Go to original source... Go to PubMed...
  5. Kawaciuk I. Urologie: Druhé vydání. Praha: Galén, 2009: 384-385.
  6. Sugaya K, Kadakawa K, Ikehara A, Nakayma T, Gakiya M, Goya M, Hatama T, Ogawa Y. Influence od hypertension on lower urinary tract symtoms in benign prostatic hyperplasia. International Journal of Urology 2003 Nov; 10(11): 569-574. Go to original source... Go to PubMed...
  7. Elbadawi A. Morphology of Aging and Dysfunction of Bladder. Drugs of Today 2001; 37: 27-31.
  8. Michel MC. Physiology and Patophysiology of Lower Urinary Tract Symptoms. Drugs of Today 2001; 37: 7-11.
  9. Smithova Všeobecná Urológia. Osvěta 2006. Prvé slovenské vydání. 389-390.
  10. Lullmann H, Mohr K, Wehling M. Farmakologie a toxikologie. Grada 2004. Překlad 15. zcela přepracované vydání: 115-116.
  11. Maruenda J, Bhatnagar V, Lowebthal DT. Hypertension in the elderly with coexisting benign prostatic hyperplasia. Urology 1999 Mar; 53(3): 7-13. Go to original source... Go to PubMed...
  12. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N´Dow J, Nordling J, de la Rosette JJ. Guidelines of the Managment fo Male Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology 2013. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.